New tests with a candidate malaria vaccine have shown it to be less effective in weeks-old infants than older babies, a "frustrating" result in the fight against the killer disease.
A woman holds her baby in her arms beneath a mosquito net at a hospital in Mogadishu, Somalia, in 2011. New tests with the world's first candidate malaria vaccine have shown that it protects a third of six- to 12-week-old infants -- less effective than in older babies, its developers said.
The trial vaccine, RTS,S, was shown in Phase III tests to protect only a third of six- to 12-week-old infants innoculated, its developers announced at a teleconference on Friday.
This article is older than 60 days, which we reserve for our premium members only.You can subscribe to our premium member subscription, here.